SCHEMBL239071

SCHEMBL239071

N#Cc1ccc(Br)nc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29648272 1.00
SCHEMBL27439055 0.87 KDM4E (0.49)
SCHEMBL17157493 0.85 CYP11B2 (0.53)
SCHEMBL15584627 0.78 CYP19A1 (0.56)
SCHEMBL5700541 0.76
SCHEMBL8113983 0.76
SCHEMBL31172969 0.75 GRM5 (0.54)
SCHEMBL995794 0.75 GRM5 (0.54)
SCHEMBL14405697 0.74 MAOB (0.56)
SCHEMBL1026572 0.73 ALDH1A1 (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1164 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111253443-A Preparation method and application of electroblotting group modified cyclometalated iridium complex 大连理工大学 2020-06-09 CN claimed
CN-103275131-A Carbazole-ring-containing metal ligand-iridium complex and preparation method and application thereof UNIV DALIAN TECH 2013-09-04 CN claimed
CN-103145763-A Novel ring metal ligand-platinum complex and preparation method and application thereof UNIV DALIAN TECH 2013-06-12 CN claimed
JP-9176122-A None JP disclosed
EP-4743081-A1 MODULATORS OF MITOCHONDRIAL DNA REPLICATION Pretzel Therapeutics, Inc. (US) 2026-05-20 EP disclosed
CN-115835909-B Cannabinoid receptor type 2 (CB 2) modulators and uses thereof 泰昂治疗公司 2026-05-15 CN disclosed
EP-3911640-B1 PCSK9 INHIBITORS FOR USE IN THERAPY, ESPECIALLY THE TREATMENT OF CARDIOVASCULAR DISEASE ASTRAZENECA AB (SE) 2026-05-13 EP disclosed
US-20260124204-A1 METALLOENZYME INHIBITOR COMPOUNDS EIKONIZO THERAPEUTICS, INC. (US) 2026-05-07 US disclosed
EP-4721737-A1 USE OF PHARMACEUTICAL COMPOSITION COMPRISING COMPOUND HAVING BIS(AZANYLYLIDENE) SULFONYL STRUCTURE FOR TREATING ANEMIA-RELATED DISEASES Scinnohub Pharmaceutical Co., Ltd. (CN) 2026-04-08 EP disclosed
US-12590067-B2 Herbicidal cyclohexanedione derivatives SYNGENTA CROP PROTECTION AG (CH) 2026-03-31 US disclosed
US-12584120-B2 PCSK9 inhibitors and methods of use thereof ASTRAZENECA AB (SE) 2026-03-24 US disclosed
EP-0700903-B1 PROCESS FOR PRODUCING CYANOPYRIDINE IHARA CHEMICAL IND CO (JP) 1997-11-12 EP disclosed
US-5675012-A REACTING AMMONIUM HALIDE WITH TRICHLOROMETHYLPYRIDINE IN PRESENCE OF A COPPER AND ZINC COMPOUND IHARA CHEMICAL INDUSTRY CO., LTD. (JP) 1997-10-07 US disclosed
JP-H09176122-A PRODUCTION OF 6-BROMONICOTINIC ACID MITSUBISHI CHEM CORP 1997-07-08 JP disclosed
EP-0700903-A1 PROCESS FOR PRODUCING CYANOPYRIDINE IHARA CHEMICAL INDUSTRY CO., LTD. (JP) 1996-03-13 EP disclosed
US-5459273-A Process for the preparation of 2-halogeno-5-cyano pyridines BAYER AKTIENGESELLSCHAFT (DE) 1995-10-17 US disclosed
US-5442064-A Anticoagulants, antiagglomerants DR. KARL THOMAE GMBH (DE) 1995-08-15 US disclosed
EP-0617021-A1 Process for the preparation of 2-halogen-5-cyanopyridines BAYER AG (DE) 1994-09-28 EP disclosed
EP-0592949-A2 N-(aminocarbonyl)-piperidines/pepirazines as aggregation inhibiting agents Dr. Karl Thomae GmbH (DE) 1994-04-20 EP disclosed
EP-0040408-A1 Beta-lactam compounds and process for production thereof SANRAKU-OCEAN CO., LTD. (JP) 1981-11-25 EP disclosed